Issue link: https://www.e-digitaleditions.com/i/1518209
Inhalation April 2024 31 Inhaled biomolecules therapies: We will launch you Merxin Ltd's MRX004 soft mist inhaler (SMI) deliv- ers biologics successfully and effectively to the lungs for local and systemic action. Its' aerosolization mech- anism does not substantially denature most biomol- ecules in contrast to some nebulizers. Because of its' efficiency, typically 70% fine particle dose, it can deliver higher doses than dry powder inhalers (DPIs) and pressurized metered dose inhalers (pMDIs). Deep lung deposition and low global warming poten- tial (GWP) are the additional benefits of our SMI. MRX004 is covered by Merxin Ltd's proprietary intellectual property and is available for in vitro and in vivo studies. Be in touch to discover our work with biologics and accelerate your entry to the market. Merxin, Ltd. UK: +44 1553 403070 info@merxin.com www.merxin.com Development through commercial manufacturing With 30+ years of inhalation experience, Catalent helps companies navigate complex product develop- ment challenges to ensure a timely development time- line. Our North Carolina, US facility provides early development capabilities for dry powders for inhala- tion and the latest in drum-based capsule filling from feasibility through Phase 1. Our lab features a Pro- cept 4M8 TriX for laboratory-scale spray drying and Harro Höfliger Drum TT capable of filling capsules, blisters, cartridges and device reservoirs accurately with 100% weight verification, plus scale-up capabil- ities via an Omnidose and Modu-C. Catalent US: + 1 888 SOLUTION (765-8846) www.catalent.com Respiratory drug product development software Fusion Process Development (FPD) for respiratory drug product R&D is the perfect companion mod- ule to Fusion Inhaler Testing (FIT) for QC. FPD has automated Design of Experiments (DoE) and data modeling for formulation and process R&D. FPD enables you to create companion testing designs for your formulation and device design studies with full bi-directional Chromatography Data Software (CDS) testing automation. Automated CDS testing and data retrieval includes handling of complex data from cas- cade impaction testing and dissolution testing. And FPD operates under full regulatory compliance to maintain data integrity. S-Matrix ® US: +1 707 441-0406 sales@smatrix.com www.smatrix.com